Researchers at the UConn Center on Aging have uncovered causal links between depression and Alzheimer’s disease and related ...

The first clinical guidelines on the use of blood biomarker tests could help clinicians choose the most appropriate test to ...

Biogen Inc. (NASDAQ:BIIB) reported on Thursday that the second quarter of 2025 adjusted earnings per share were $5.47, up 4% ...

A new study shows that the way amyloid proteins—implicated in Alzheimer's disease—assemble into fibrils can be significantly ...

In the early stages of Alzheimer’s disease, people may have trouble following conversations, repeat themselves, or struggle ...

Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...

Let’s keep it simple: If you want to delay Alzheimer’s onset, focus on walking and adding nutritious foods, such as walnuts, ...

A hit Bollywood film sparks public curiosity about early-onset Alzheimer’s — experts break down its causes, symptoms, and how ...

New tests and new treatments are presenting more options for certain patients with Alzheimer's disease.

TORONTO -- Biomarkers pointing to increased risk for Alzheimer's disease were markedly reduced with the investigational cholesteryl ester transfer protein (CETP) inhibitor obicetrapib relative to ...

However, some research suggests that poor sleep could raise your risk of Alzheimer’s. A study published in November found ...

Dr. Ausim Azizi is among those seeing the overall early results, as Yale New Haven Hospital is in the forefront of research ...